论文部分内容阅读
在临床工作中,为了有效地控制各种心律失常,减少其副作用,抗心律失常药物的联合应用日益增多。因此,要注意联合应用时的药物相互作用,在某些情况下能引起致命性心律失常,若不及时发现和有效地正确处理,常可导致严重后果,在联合应用抗心律失常药物时要提高警惕。现将我院二例联合应用抗心律失常药物引起伴有 Q—T 间期延长的扭转型室性心动过速报告如下。由于此种致命性心律失常的临床表现、心电图特征
In clinical work, in order to effectively control a variety of arrhythmias and reduce their side effects, combined use of antiarrhythmic drugs is increasing. Therefore, pay attention to drug interactions when used in combination, in some cases can cause fatal arrhythmia, if not detected and effectively correct treatment, can often lead to serious consequences, the combination of anti-arrhythmic drugs should be increased alert. Now in our hospital two cases of anti-arrhythmic drugs combined with anti-Q-T prolongation caused by ventricular tachycardia reported as follows. Due to the clinical manifestations of such fatal arrhythmias, ECG characteristics